ZVC-30216-25650
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 390 / MS
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-28
- 2021-01-04
-
2021-01-11
Survey response — day 21, dose 1MedDRA: Fatigue, Headache, Myalgia, SARS-CoV-2 test — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professionalFree text: Symptoms: Persistent headache, fatigue, muscle aches · Healthcare visit (other): Covid 19 swabMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — day 21, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-01-19
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-23
- 2021-02-24
-
2021-04-14
Survey response — 3 months, dose 2MedDRA: Oropharyngeal pain, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: GoodFree text: Post nasal drip, sore throat, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-14
-
2022-01-13
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-11 | Unsuccessful |
Free text
Release 1 — day 21, dose 1
Symptoms: Persistent headache, fatigue, muscle aches
Healthcare visit (other): Covid 19 swab
Release 7 — 3 months, dose 2
Symptoms: Post nasal drip, sore throat, congestion
Release 10 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release